Gilead and Kite nab an­oth­er ap­proval for Tecar­tus, as lead­ing CAR-T port­fo­lio con­tin­ues to grow

4 years ago
FDA+

At­las cre­ates sec­ond op­por­tu­ni­ty fund with $300M; BioN­Tech's col­orec­tal can­cer vac­cine starts PhII tri­al

4 years ago
News Briefing

Pfiz­er los­es close­ly watched court case on kick­backs and sub­si­diz­ing drugs

4 years ago
Pharma

Clos­ing out a qui­et week on Wall Street, a new SPAC prices its pub­lic de­but and be­gins the search for a biotech ...

4 years ago
Financing

An FDA mis­take sig­nals like­ly ap­proval for first ther­a­py for chil­dren born with­out a thy­mus

4 years ago
Pharma
FDA+

Unit­ed Ther­a­peu­tics tran­si­tions to pub­lic ben­e­fit cor­po­ra­tion more than 20+ years af­ter IPO

4 years ago
Pharma

Emer­gent lands an­oth­er big mon­ey con­tract from BAR­DA for an­thrax

4 years ago
Deals
Manufacturing

Avoro Cap­i­tal, the deal killer be­hind the Seagen-Im­munomedics blowup, has turned its eyes on Mer­ck­'s Ac­celeron buy­out

4 years ago
Pharma

Omeros stock craters as FDA cites de­fi­cien­cies in ap­pli­ca­tion for HSCT-TMA drug

4 years ago
FDA+

Af­ter years of run­ning tri­als for oth­er drug­mak­ers, Tri­alSpark is build­ing its own pipeline

4 years ago
Financing

Mer­ck claims pan­dem­ic break­through: Covid-19 pill re­duces hos­pi­tal­iza­tion and death by 50%

4 years ago
R&D
Coronavirus

The cash won't stop for Ex­sci­en­tia as it makes a $300M+ Nas­daq de­but

4 years ago
Financing

Black­list Chi­nese ge­net­ic se­quenc­ing com­pa­nies, law­mak­ers ar­gue — cit­ing po­ten­tial for 'bioweapons,' na­tion­al ...

4 years ago
China

Covid-19 roundup: Hu­man er­ror to blame for steel found in Mod­er­na vials; Flu and Covid-19 shots safe to be tak­en ...

4 years ago
Coronavirus

Cat­a­lyst wins re­ver­sal in or­phan ex­clu­siv­i­ty court bat­tle with FDA

4 years ago
Pharma
FDA+

Sporos Bioven­tures taps first CEO dur­ing pe­ri­od of 'ex­plo­sive growth'; In the wake of murky Hunter syn­drome da­ta, ...

4 years ago
Peer Review

Eli Lil­ly is­sues re­sponse to Form 483 at In­di­anapo­lis plant

4 years ago
Manufacturing

Fresh off a big pan­dem­ic year, Ther­mo Fish­er an­nounces more growth at its Mid­west hub

4 years ago
Manufacturing

Re­call re­port: Eli Lil­ly pulls di­a­betes emer­gency kit af­ter man­u­fac­tur­ing mishap

4 years ago
Manufacturing

Cy­ti­va pledges $52.5M in­to South Ko­re­an op­er­a­tions as it ex­pands glob­al plans

4 years ago
Manufacturing

New House bill aims to shore up US API pro­duc­tion in re­sponse to pan­dem­ic short­ages

4 years ago
Manufacturing

Bris­tol My­ers re­ports short­age of chemo drug abrax­ane; Sar­to­rius more than dou­bles ca­pac­i­ty with Michi­gan ex­pan­sion

4 years ago
Manufacturing

Glax­o­SmithK­line, Mer­ck KGaA of­fi­cial­ly call it quits on $4B part­ner­ship for flail­ing can­cer drug

4 years ago
R&D

Ot­su­ka puts near­ly $1 bil­lion on the line for four neu­ropsy­chi­atric can­di­dates from Sunovion

4 years ago
Deals
First page Previous page 642643644645646647648 Next page Last page
A service from the Financial Times